Zum Inhalt springen

Case Study: GSK Optimizes Enterprise-wide Visibility

Innovation | IP-Strategie
GSK Optimizes Enterprise-wide Visibility with ideaPoint
Tags: ideaPoint, External Innovation & Partnering

World health depends on the pragmatic research, development, discovery and commercialization of new drugs and treatments. But for the healthcare and pharma industry, developing new products can be an extremely lengthy and expensive investment, even for those companies who maintain their own private research staff and R&D centers.

For global companies like GSK and others, collaboration with outside R&D partners has become a critical component to meeting global healthcare needs. Partner collaboration allows even the largest pharma companies to expand their portfolios, and address new markets by collaborating with a multitude of smaller, highly innovative research teams located across the globe. Partnerships also provide strategic value by compressing new product timelines that typically last 12 years or more.